Help us learn about an investigational vaccine that may increase protection from different types of pneumococcal disease
INFANT PNEUMOCOCCAL VACCINE STUDY
PNEUMOCOCCAL DISEASE FACTS
0
Americans get pneumococcal pneumonia each year0
hospitalizations from pneumococcal pneumonia are estimated to occur annually in the United StatesSTUDY INFORMATION
This is a of an investigational vaccine that may increase protection from different types of pneumococcal disease. Your child may be eligible to participate in this study if he or she:
Is healthy, between 42–98 days of age and has not received a pneumococcal vaccine or a Hepatitis B vaccine after 1 month of age. If your child is eligible for the study, he or she will be in the study for approximately 16 months. You will need to bring your child to the study clinic 6 times and complete one visit over the phone.
MEDICAL CONDITION
Must be healthy and not received a Pneumococcal vaccine or a Hepatitis B vaccine after 1 month of age
GENDER
all
COMPENSATION
You may be compensated for time and travel
LOCATION
Metairie, LA
ENROLLMENT
Active
AGE RANGE
42–98 days of age
COMMITMENT
16 months
NUMBER OF VISITS
6 clinic visits and 1 visit over the phone
IS YOUR BABY BETWEEN 42–98 DAYS OF AGE?
If so, your child may be able to participate in this study